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Turning the fate of reprogramming 
cells from retinal disorder to 
regeneration by Pax6 in newts
Martin Miguel Casco-Robles1, Md Rafiqul Islam2, Wataru Inami3, Hibiki Vincent Tanaka3, 
Ailidana Kunahong3, Hirofumi Yasumuro3, Shiori Hanzawa3, Roman Martin Casco-Robles3, 
Fubito Toyama4, Fumiaki Maruo1 & Chikafumi Chiba1
The newt, a urodele amphibian, has an outstanding ability– even as an adult –to regenerate a functional 
retina through reprogramming and proliferation of the retinal pigment epithelium (RPE) cells, even 
though the neural retina is completely removed from the eye by surgery. It remains unknown how the 
newt invented such a superior mechanism. Here we show that disability of RPE cells to regenerate the 
retina brings about a symptom of proliferative vitreoretinopathy (PVR), even in the newt. When Pax6, 
a transcription factor that is re-expressed in reprogramming RPE cells, is knocked down in transgenic 
juvenile newts, these cells proliferate but eventually give rise to cell aggregates that uniformly express 
alpha smooth muscle actin, Vimentin and N-cadherin, the markers of myofibroblasts which are a major 
component of the sub-/epi-retinal membranes in PVR. Our current study demonstrates that Pax6 is an 
essential factor that directs the fate of reprogramming RPE cells toward the retinal regeneration. The 
newt may have evolved the ability of retinal regeneration by modifying a mechanism that underlies the 
RPE-mediated retinal disorders.
In contrast to other vertebrates including humans, the newt (a group of urodele amphibians classified into the 
family of Salamandridae) can regenerate, even as an adult, an entire retina from retinal pigment epithelium (RPE) 
cells1,2. In adult vertebrate eyes, the RPE is a highly differentiated monolayer-cell-sheet laminating the back of the 
neural retina (NR) and functions as a partner of the NR for vision. Mature RPE cells, as a rule, do not proliferate 
under physiological conditions. In the adult newt, RPE cells in the intact eye are also mitotically inactive, but 
when the NR is removed from the eye by surgery (retinectomy), RPE cells lose their epithelial characteristics and 
detach from each other as well as from the basement membrane (Bruch’s membrane), giving rise to the aggregates 
of mesenchymal-like cells with multipotency, named RPE stem cells (RPESCs), in the vitreous cavity. RPESCs are 
subsequently divided into two cell populations which undergo proliferation, so that they can differentiate in the 
correct polarity into two epithelial layers of progenitor cells (named pro-NR and pro-RPE layers) that eventually 
regenerate new functional NR and RPE, respectively3.
It remains unknown how such a sophisticated mechanism for retinal regeneration evolved in the newt. It 
would be difficult to understand this mechanism solely by the mechanisms underlying RPE-to-NR transdiffer-
entiation which can be induced in a restricted time frame during embryonic development in amniotes. In these 
cases, the RPE does not lose its epithelial characteristics, but directly switches into the neuroepithelium while 
preserving its original polarity, giving rise to the NR with inverse polarity while losing the RPE2–4. On the other 
hand, our recent studies revealed a similarity in early behaviour of RPE cells between adult newt retinal regener-
ation and human retinal disorders such as proliferative vitreoretinopathy (PVR)3,4. In PVR, when the NR suffers 
a wound from a traumatic injury, RPE cells – as in the newt – start to lose their epithelial characteristics while 
acquiring the ability to migrate and proliferate. However, unlike in the newt, these cells eventually transform 
into myofibroblasts, a major component of both the epi- and sub-retinal membranes which close the wound of 
the NR, but finally withdraw the NR by contraction, leading to a loss of vision. In this process of transformation 
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Figure 1. Retinal regeneration in control condition. (a) Time schedule of experiments. One-cell stage 
embryos were microinjected with a solution containing both a Cre driver construct (RPE65 > CreERT2-
CAGGs > YFP) and a loxP reporter/shRNA construct (CAGGs > [AmCyan]mCherry-shRNA). On the sixth 
day after injection, blastula embryos (St. 10) that uniformly expressed intense fluorescence of both YFP and 
AmCyan were screened. Swimming larvae at St. 58–59 (~4 months old) were incubated in a rearing solution 
containing 4 μ M (Z)-4-Hydroxytamoxifen (4-OHT) for 48 h. Juvenile newts around 7 months old (1–2 months 
after metamorphosis) were subjected to surgical removal of both the lens and the neural retina under anesthesia 
and then allowed to recover for the study of retinal regeneration. (b,c) Representative of regenerated retinas 
at Stage L-2 (n = 4). mCherry fluorescence was observed in the central retina (box). The image is enlarged in 
(c). mCherry fluorescence was localized in both RPE cells and cells in the regenerated NR. In the regenerated 
NR, the mCherry+ cells composed a column structure similar to those observed in embryonic retinal 
development7–9. The column structure was comprised of all kinds of retinal neurons and glia. Interestingly, as 
in retinal development9, cell bodies of the horizontal cells were located distant from the body of the column. 
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(classified as the epithelial-mesenchymal transition, or EMT), it has been suggested that RPE cells pass through 
a multipotent state4. Such multipotent RPE cells in humans, which were also named RPESCs, are regarded as the 
cells corresponding to the newt RPESCs3,4.
Perhaps, in the newt something may have happened in early processes of retinal disorders like PVR during 
evolution, so that the fate of RPESCs was directed toward retinal regeneration. If this is the case, when retinal 
regeneration in the newt is impaired in early processes, symptoms of PVR would become apparent. In this study, 
we examined this hypothesis. For this, we created for the first time a transgenic newt enabling RPE-targeted gene 
regulation and successfully hindered retinal regeneration by knocking down the expression of Pax6 in RPESCs. 
Pax6 is a transcription factor which is re-expressed in RPESCs and then up-regulated in the pro-NR layer while 
down-regulated in the pro-RPE layer3.
Results
Conditional RPE-targeted gene knockdown system. We created transgenic newts (Cynops pyrrho-
gaster) to specifically express shRNA as well as a fluorescent reporter protein mCherry in both mature RPE cells 
and cells that originate from those RPE cells after retinectomy. These animals carried DNA encoding either con-
trol shRNA (C-shRNA) or Pax6 shRNA (Pax6 shRNA-2), which was located between the stop codon and the 
polyA terminal in the mCherry gene (Supplementary Fig. 1). These shRNAs were examined in our previous 
study3, and Pax6 shRNA-2 proved to effectively inhibit Pax6 expression in this species. In this study, we used 
juvenile newts around 7 months old (1–2 months after metamorphosis). They were incubated at the swimming 
larva stage (St. 58–59; around 4 months old) in a rearing solution containing 4 μ M (Z)-4-Hydroxytamoxifen 
(4-OHT) for 48 h. In this condition, Cre-mediated recombination leading to mCherry-shRNA expression was 
almost restricted in the central area of the RPE in metamorphosed newts (Supplementary Figs 2 and 3): in juve-
nile newts around 7 months old, more than 70% of the cells in the central RPE (45°–135°) and less than 30% of 
the cells in the peripheral RPE were mCherry+ . In addition, all transgenic newts used in this study displayed no 
abnormalities in eye development or in NR/RPE morphology.
Retinal regeneration in the control condition. In the control condition with C-shRNA, retinal regenera-
tion occurred normally (Fig. 1). We carried out retinectomy in ~7 months old juveniles (Fig. 1a). In the eyes at ~2 
months post operation (po) when the retina had regenerated (Stage L-2), mCherry fluorescence was observed in 
both the NR and the RPE (Fig. 1b,c) as anticipated from our previous study3. However, in the NR, the mCherry+ 
area was restricted to the centre. It is known in growing eyes of juvenile newts that retinal stem/progenitor cells 
at the periphery of the NR (i.e., the ciliary marginal zone; CMZ), which is reserved from embryonic eye develop-
ment, are still active, and their contribution to regeneration (or regrowth) of peripheral NR is very high compared 
to the adult5,6. In fact, also in our newts, a cell layer of the CMZ grew quickly toward the centre along the RPE 
upon retinectomy and met a pro-NR layer which formed slowly from the central RPE (Fig. 1d–f), eventually 
regenerating a large part of the NR (70–90% of its radius) while the remnant central NR was regenerated from the 
RPE (see the schematic in Fig. 1g). Participation of the peripheral RPE in the retinal regeneration was probably 
inhibited by association with the cell layer growing quickly from the CMZ. In the central NR, mCherry fluores-
cence was observed in all kinds of retinal neurons and glia (Fig. 1c). In particular cases, we recognized a column 
structure of NR cells (Fig. 1c and Supplementary Movie 1). Surprisingly, it resembled a column of descendants 
which originate from a single retinal progenitor cell in embryonic retinal development7–9. This finding is sufficient 
for us to believe that a single RPE-derived pro-NR cell is capable of producing one set of NR cells, being compa-
rable to the retinal progenitor cell.
Retinal regeneration in the Pax6 knockdown (Pax6 KD) condition. In the Pax6 KD condition, obvi-
ous abnormalities appeared in the behavior of RPE cells as regeneration proceeded beyond Stage E1 (typically 
10 days po) when RPE cells had become mesenchymal-like cells, which start to express Pax6 in normal retinal 
regeneration3,10 (Figs 2 and 3). In the eyes on 26 days po, when the thickness of a regenerating NR originating 
from the CMZ (CMZ-NR) had increased (Stage I-1 to I-2), lightly pigmented cells expressing mCherry, i.e., 
RPE-derived cells, gathered in between the leading ends of the CMZ-NR (Fig. 2a,b; see the schematic in Fig. 2g). 
However, unlike in the control condition, these cells were not integrated into one continuous regenerating NR. 
Immunohistochemistry demonstrated that Pax6 expression in those cells had been efficiently blocked (see 
Fig. 3b). On 50 days po when the CMZ-NR, in which the plexiform layers had just appeared (Stage I-3 to L-1), 
started fusing at its leading ends so that a hole in the centre of the regenerating NR closes, such Pax6-less (∆ Pax6) 
RPE-derived cells had moved out to the vitreous cavity, creating a fibrous structure along the vitreal surface of 
the NR (Fig. 2c,g). We examined the proliferative activity of the RPE-derived cells (Fig. 2d–f). Cells in the centre 
of the RPE mostly re-entered the cell cycle by Stage E1 and proliferated (Fig. 2e), although activity decreased to 
Note that in mCherry+ NR cells fluorescence of AmCyan was decreased (Cyan), indicating that Cre-mediated 
recombination successfully took place in parental RPE cells. Br: brain; ONL: outer nuclear layer; OPL: outer 
plexiform layer; INL: inner nuclear layer; IPL: inner plexiform layer; GCL: ganglion cell layer. Scale bars: 100 μ m.  
(d–f) Contribution of the endogenous retinal stem/progenitor cells in the CMZ during retinal regeneration. 
Nuclei were counterstained with DAPI. Regenerating NR originating from the CMZ (arrow heads) had covered 
a large area of the RPE before the central RPE cells reached Stage E1 (right-hand box) to E2 (left-hand box) 
(n = 7). The images in these boxes are enlarged in (e,f) respectively. Dotted line in (e) shows Bruch’s membrane 
and that in (f) shows the outer margin of the regenerating NR. The arrow in (f) indicates a junction (called the 
Splayed-joint1) between the CMZ-originating (non-pigmented; left-hand) and RPE-originating regenerating 
NR (partially pigmented; right-hand). Scale bars: 100 μ m. (g) Summary of results.
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~80% of the control, and the cells derived from those RPE cells, i.e., ∆ Pax6 RPE-derived cells, mostly exited the 
cell cycle by 26 days po (Fig. 2d,f). The ∆ Pax6 RPE-derived cells at this stage had lost the RPE marker, RPE65 
(Fig. 2d). Consequently, Pax6 KD hardly altered dedifferentiation (loss of original characteristics) and prolifera-
tion of RPE cells, but seriously impacted their transdifferentiation into the NR.
Regeneration of the central RPE was also observed later than 26 days po (Fig.  2). However, pig-
mented cells along or near Bruch’s membrane did not express mCherry (Fig. 2b). Instead, we observed Pax6 
Figure 2. Retinal regeneration in Pax6 KD condition. (a) Regenerating retinas on 26 days post operation 
(op) (n = 5). (b) mCherry-immunolabeling of a neighbouring section of (a). The tissue was bleached. Lightly 
pigmented cells gathered in between the leading ends of CMZ-originating regenerating NR (CMZ-NR) (a). 
mCherry-immunoreactivity was localized in those cells (n = 4) (b). Pax6 expression in those cells was efficiently 
inhibited (see Fig. 3b). Arrowhead: a junction of leading ends of the CMZ-NR. Note that the cells in between 
Bruch’s membrane (dotted line in magenta) and the outer margin of the regenerating NR, i.e., in a region of 
prospective central RPE, had no mCherry-immunoreactivity (n = 3). (c) Regenerating retinas on 50 days po 
(n = 3). The section was labelled with Pax6 antibody and bleached. Pax6-less RPE-derived cells composed a 
fibrotic structure (FS) along the vitreal surface of the CMZ-NR (NR). Note that a small number of nuclei in the 
structure showed Pax6-mmunoreactivity. These cells probably migrated from the CMZ-NR (see Fig. 3). At this 
stage, Pax6-immunoreactivity became recognizable in the cells constructing a new central RPE. (d) RPE65− 
and PCNA-immunoreactivity in RPE-derived cells on 26 days po (n = 3). Arrowheads indicate PCNA+ nuclei. 
RPE65+ cells in a region of prospective central RPE seemed to have migrated from the surrounding RPE, and 
were mostly mitotically active (PCNA+ ). The cells on the margin of the surrounding RPE were also PCNA+ .  
On the other hand, Pax6-less RPE-derived cells which gathered in between the leading ends of the CMZ-NR 
had lost RPE65-immunoreactivity and were rarely PCNA+ . Note that green fluorescence surrounding 
migrating RPE cells and within the CMZ-NR were non-specific binding of PCNA antibody (see Methods). 
To-Pro-3: nucleus. L: Regenerated lens. Asterisk: Pigmented phagocyte1. Scale bars: 100 μ m. (e) Comparison of 
the proportion of PCNA+ cells in all RPE-derived cells at Stage E-1 between the Pax6 KD (10 days po; n = 4) 
and the control (10 days po; n = 4) conditions. The mean value was significantly lower in Pax6 KD (Student’s 
t-test, P = 0.0017). (f) Proportion of PCNA+ cells in all RPE-derived cells without (RPE65−) or with RPE65− 
immunoreactivity (RPE65+ ) on 26 days po in the Pax6 KD condition (n = 3). The mean value was significantly 
lower in RPE65- (Student’s t-test, P = 0.0015). (g) Summary of results.
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immunoreactivity in those cells on 50 days po (Fig. 2c), indicating that the central RPE originated from the cells 
in which Cre-mediated recombination did not take place. It is likely that most of those cells migrated from the 
margin of the surrounding RPE, whose participation in NR regeneration was inhibited by tissue that originated 
from the CMZ. In fact, on 26 days po, cells in the prospective central RPE exhibited RPE65 immunoreactivity 
as in the surrounding RPE, and those cells were cycling as were the cells in the margin of the surrounding RPE 
(Fig. 2d). Consequently, ∆ Pax6 RPE-derived cells did not contribute to the renewal of RPE (Fig. 2g). Taken 
together, our results demonstrated that Pax6 expression in RPE-derived cells was essential for them to regenerate 
both the NR and the RPE.
Appearance of epi-/sub-retinal membrane-like phenotype by Pax6 KD. We addressed whether 
impairment of retinal regeneration by Pax6 KD in RPE cells resulted in the appearance of symptoms of 
RPE-mediated retinal disorders. In human PVR, RPE cells undergo EMT, giving rise to myofibroblasts, which 
are a major component of the sub- and epi-retinal membranes4. In this study, using immunohistochemistry, we 
Figure 3. Appearance of epi-/sub-retinal membrane-like phenotype by Pax6 KD. (a–f) Representatives 
showing immunoreactions of Pax6-less RPE-derived cells on 26 days po (n = 5). NR: regenerating neural retina 
originating from the ciliary marginal zone. To-pro-3: nucleus. Scale bar (adapted to all panels): 100 μ m.  
(a) Translucent image of a section. (b,c) Double labelling of the same section with Pax6 and alpha smooth 
muscle actin (aSMA) antibodies. (d–f) Labelling with Vimentin (Vim), N-cadherin (NCAD) and glial fibrillary 
acidic protein (GFAP) antibodies in different sections. Almost all of the Pax6-less RPE-derived cells in 
aggregates expressed aSMA, Vim and NCAD. On the other hand, GFAP immunoreactivity was localized in a 
small number of fibroblastic cells near the NR as well as in the NR, suggesting the migration of cells (possibly 
retinal progenitor cells) in the NR. Darkly pigmented cells in aggregates are ‘pigmented phagocytes’ that also 
appear in normal retinal regeneration1 (also see Fig. 2). Note that Pax6+ cells in aggregates (b) which seem to 
have migrated from NR, also expressed aSMA. (g) Schematic of conclusion.
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examined the expression of markers of RPE-derived myofibroblasts, such as alpha smooth muscle actin (aSMA), 
Vimentin and N-cadherin4,11, in ∆ Pax6 RPE-derived cells (Fig. 3). Surprisingly, aggregates of ∆ Pax6 RPE-derived 
cells, which had migrated from their original place on Bruch’s membrane and gathered in between the leading 
ends of the CMZ-NR, expressed aSMA, Vimentin and N-cadherin uniformly (Fig. 3c–e). We further examined 
the expression of glial fibrillary acidic protein (GFAP), another marker of epi- and sub-retinal membranes4. GFAP 
immunoreactivity was localized in fibroblastic cells near the leading ends of the CMZ-NR (Fig. 3f). These cells 
may have migrated from regenerating NR. GFAP is known to be expressed in both retinal progenitor cells and 
Müller glia cells12. In PVR, Müller cells in an injured NR also contribute to the epi- and sub-retinal membranes4. 
Taken together, Pax6 KD in RPE-derived cells resulted in a structure with a similar phenotype to the epi- and 
sub-retinal membranes (Fig. 3g).
Discussion
In this study, we successfully hindered RPE-originating retinal regeneration in the newt by knocking down 
Pax6 in RPE-derived cells. We must note here that in the juvenile eyes examined, the contribution of the CMZ 
to retinal regeneration was so high that the area in which RPE-originating retinal regeneration took place was 
restricted to the central retina. In the Pax6 KD condition, RPE-derived mesenchymal-like cells were able to 
migrate and proliferate but eventually differentiated into cells like myofibroblasts, suggesting that the newt RPE 
cells underwent EMT. Furthermore, cellular components of the resulting structure were similar to those of epi- 
and sub-retinal membranes. In conclusion, inhibition of the retinal regeneration resulted in the appearance of 
symptoms of RPE-mediated retinal disorders like PVR. Possibly, adult newts may have invented the ability of 
retinal regeneration by revising the program underlying EMT of RPE cells upon retinal trauma, so that the fate of 
RPESCs is directed toward the retinal regeneration. Clearly, in the newt, Pax6 is an essential player for this process 
with a novel function enabling RPESCs to self-organize into two progenitor layers (epithelium) which eventually 
regenerate the NR and the RPE.
In a previous study, we demonstrated that Pax6 KD in embryonic development resulted in a missing eye in the 
newt, suggesting that the function of Pax6 as a master regulator of eye morphogenesis is also conserved in this 
animal3. In the current study, we examined the function of Pax6 in a different context, i.e., retinal regeneration 
from terminally differentiated RPE cells, that is unique to this animal. However, comparison with eye develop-
ment may be helpful to understand Pax6 function in this system. In our previous study, we proposed that RPESCs 
might substantially correspond to the cells in the early optic vesicle although RPESCs preserved their original 
characteristics3. Furthermore, we hypothesized, as an analogy to optic cup formation, that Pax6 might have a role 
in the fate decision of RPESCs to differentiate either the NR or the RPE as the cells formed two progenitor layers10. 
However, in the current study, we demonstrated that in the Pax6 KD condition, RPE-derived cells differentiated 
into neither the NR nor the RPE, but rather into myofibroblast-like cells. These findings suggest that Pax6 is 
essential for RPE cells to be reprogrammed into normal RPESCs which have the potency to differentiate into both 
the NR and the RPE (Fig. 3g). In speculation, RPE cells might substantially dedifferentiate to the state near the 
eye field from which the optic vesicle is formed. Given this, the time point at which Pax6 functioned at first was 
earlier than anticipated, and therefore the previous hypothesis was not evaluated in this study. However, we know 
that once RPESCs are generated, they undergo regulation of Pax6 and are sorted into two cell populations3. One 
population in which Pax6 is up-regulated forms the pro-NR layer, while the other population forms the pro-RPE 
layer3. Therefore, the function of Pax6 in cell fate decision is reasonable. Note that in this stage a mesenchymal 
to epithelial transition (MET)-like event takes place in both progenitor layers. Our Pax6 KD system can target 
RPESCs, and therefore we will pursue this issue in the future.
It would be difficult to understand by comparison with eye development how normal reprogramming by Pax6 
prevents RPE cells from transforming into myofibroblast-like cells. This issue would be of mature RPE cells. Pax6 
may function even as a key factor that revises a default program which is booted in mature RPE cells after retinal 
injury and leads them to EMT. It must be noted here that Pax6 may be expressed in human RPESCs which give 
rise to myofibroblast cells in PVR3,4. In the newt, something might have happened in RPE cells during evolution 
so that Pax6 can work properly for retinal regeneration while inhibiting EMT. Further understanding of how 
Pax6 works in reprogramming RPE cells in the adult newt in comparison with the homologous system in humans 
is necessary not only to uncover the changes that occurred in the newt during evolution but also to unlock the 
potency of in vivo retinal regeneration from RPE cells in humans. These findings would lead, in the future, to a 
novel clinical treatment of RPE-mediated retinal disorders that inhibits the EMT of RPE cells while promoting 
retinal regeneration in the eyes of patients.
Methods
All methods were carried out in accordance with Regulations on the Handling of Animal Experiments in 
University of Tsukuba (RHAEUT). All experimental protocols were approved by Committee for Animal 
Experiments in University of Tsukuba (CAEUT).
Animals. Toride-Imori, a race of the Japanese fire-bellied newt C. pyrrhogaster, was used for this study13. 
Fertilized eggs were obtained from adult animals (total body length: male, ~9 cm; female, 11–12 cm)13. 
Developmental stages were determined according to previous criteria13.
Transgenesis for RPE-targeted Pax6 knockdown. To block the expression of Pax6 in both mature RPE 
cells and cells originating from those RPE cells after retinectomy, two plasmids, pRPE65 > CreERT2-CAGGs > YFP 
(I-SceI) and pCAGGs > [AmCyan]mCherry-shRNA (I-SceI), were constructed based on cpRPE65-mcherry0114 
and pCAGGs-mCherry-shRNA (Sce)3 using standard molecular cloning procedures (Supplementary Fig. 1a). In 
www.nature.com/scientificreports/
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pRPE65 > CreERT2-CAGGs > YFP (I-SceI), the C. pyrrhogaster RPE65 promoter, which is specifically activated 
in RPE cells as they reach terminal differentiation14, was used to drive the expression of an inactive form of Cre 
recombinase CreERT2, and a fluorescent protein YFP, which is expressed under the control of a ubiquitous pro-
moter CAGGs13, was used to monitor the transgenic state. In pCAGGs > [AmCyan]mCherry-shRNA (I-SceI), a 
gene of the fluorescent protein AmCyan (Z2440N; Takara Bio, Shiga, Japan) was flanked by loxP sites, and a DNA 
sequence encoding Pax6 shRNA-2 or control shRNA (C-shRNA) was inserted between the stop codon and the 
polyadenylation terminal in a gene of the other fluorescent protein mCherry. In the presence of the activated Cre, 
AmCyan expression, which is driven by CAGGs and was monitored to evaluate the transgenic state, is switched to 
mCherry-shRNA expression. The design and specificity of shRNA have been described in our previous paper3. In 
both plasmids, the transgene cassette was flanked by I-SceI meganuclease recognition sites. The chicken β -globin 
HS4 2× core insulator was inserted into the cassette to minimize possible cis interactions within the cassette and 
between the cassette and functional elements on the chromosome. The HS4 insulator was a kind gift from Dr. 
Gary Felsenfeld (National Institute of Health, Bethesda, MD, USA).
Transgenesis was carried out using the I-SceI protocol13 (Supplementary Fig. 1b). Two plasmids (described 
above) and I-SceI enzyme (catalogue #R06945; New England Biolabs, Tokyo, Japan) were co-injected 
into one-cell stage embryos. Components of the injected solution (4 nl per embryo) were as follows: 
pRPE65 > CreERT2-CAGGs > YFP (I-SceI), 40 ng μ l−1; pCAGGs > [AmCyan]mCherry-shRNA (I-SceI), 40 ng μ l−1; 
I-SceI, 1 U μ l−1; I-SceI buffer (New England Biolabs), 1X; phenol red, 0.01%. The injected embryos were incubated 
until the 4-cell stage at 12 °C overnight. When the embryos reached the blastula stage (St. 10), the animals that 
expressed both YFP and AmCyan in their entire body almost evenly were screened under a fluorescence dissect-
ing microscope (M165 FC; Leica Microsystems, Wetzlar, Germany) (Supplementary Fig. 1c). They were reared 
until the swimming larva stage (St. 58–59) at 22 °C. Leaky expression of mCherry was not detected during devel-
opment (Supplementary Fig. 1c). To induce Cre-mediated recombination, when swimming larvae reached St. 
59 (just before metamorphosis), they were transferred into 0.1X Holtfreter’s solution13 (pH 7.4) containing 4 μ M 
4-OHT [(Z)-4-hydroxytamoxifen; Sigma-Aldrich, MO 63103, USA] and 1% (v/v) dimethylsulfoxide (DMSO), 
and incubated for 48 h at 22 °C in the dark (the solution was exchanged to a fresh solution after 24 h incubation) 
(Supplementary Fig. 2a). For the control, animals were incubated in 0.1X Holtfreter’s solution containing 1% (v/v) 
DMSO only. After 4-OHT treatment, animals were transferred into 0.1X Holtfreter’s solution at 22 °C until meta-
morphosis. Metamorphosed juveniles were transferred into moist chambers and reared until surgery.
Anesthesia. Juvenile newts were anesthetized in water containing 0.05% (v/v) FA-100 (4-allyl-2-methoxyphenol; 
DS Pharma Animal Health, Osaka, Japan) for 15 min at 20 °C in the dark. Anesthetized animals were rinsed in 
distilled water and air dried on moist paper towels until surgery.
Retinectomy. Juvenile newts around 7 months old (1–2 months after metamorphosis; total body length: 3.5–4.0 cm) 
were subjected to surgical removal of both the lens and the neural retina under anesthesia. Animals were placed 
under a dissecting microscope (M165 FC). The dorsal half of the eye was cut open along the corneal-scleral junc-
tion, and the neural retina was carefully removed together with the lens1. After surgery, animals were allowed to 
recover and kept in moist chambers at 20 °C until experiments.
Tissue preparation. Eyeballs were carefully removed from animals under anesthesia. A fragment of the dorsal 
eyelid was left on the eyeballs. For direct observation of reporter fluorescence (mCherry, Cyan, and YFP), eyeballs 
were fixed in phosphate-buffered saline (PBS; pH 7.4) containing 4% (w/v) paraformaldehyde and 0.25% (v/v ) 
glutaraldehyde for 6 h at 4 °C (Fig. 1b,c and Supplementary Fig. 1c). Note that this fixation condition was too 
strong to detect gene expression by immunohistochemistry. For immunohistochemistry, eyeballs were fixed in 
modified Zamboni’s solution [2% (w/v) paraformaldehyde and 0.2% (w/v) picric acid in PBS (pH 7.4 )] for 6 h at 
4 °C (Fig. 2, Fig. 3 and Supplementary Figs. 2 and 3). Note that in this condition, reporter fluorescence was dimin-
ished, while red autofluorescence sometimes appeared along the outer segments of photoreceptors and red blood 
cells in the choroid (Supplementary Fig. 3b). Fixed eyeballs were thoroughly rinsed in PBS at 4 °C (5 min × 3, 
10 min × 3, 30 min × 3, 1 h × 3, and overnight), transferred to 30% sucrose in PBS at 4 °C and incubated until 
the eyeballs were completely submerged (7–9 h). They were embedded into Tissue-Tek O.C.T compound (4583; 
Sakura Finetek USA, CA 90501, USA) and cryosectioned at ~20 μ m thickness along the dorsoventral axis1.
Immunohistochemistry. Primary antibodies used were as follows: mouse monoclonal anti-Pax6 antibody 
(1:200; AD2.38, sc-32766; Santa Cruz Biotechnology, TX 75220, USA), anti-RPE65 antibody (1:500; MAB5428; 
EMD Millipore, CA 92590, USA), anti-Vimentin antibody [Vim 3B4] (1:250; ab28028; Abcam, Tokyo 103–0012, 
Japan) and Cy3 conjugated anti-GFAP antibody (1:600; G-A-5-Cy3; C9205; Sigma-Aldrich); rabbit polyclonal 
anti-RFP antibody (for mCherry; 1:200–500; 600-401-379; Rockland Immunochemicals, PA 19468, USA), 
anti-aSMA antibody (1:500; ab137734; Abcam) and anti-N Cadherin (1:400; ab12221; Abcam); human PCNA 
autoantibody1 (1:1000). Secondary antibodies were as follows: Alexa 488-conjugated goat anti-mouse IgG (H + L) 
antibody (1:500; A11001; Thermo Fisher Scientific, Yokohama, Japan), anti-rabbit IgG (H + L) antibody (1:500; 
A11034; Thermo Fisher Scientific) and anti-human IgG antibody (1:1,000; A11013; Thermo Fisher Scientific); 
tetramethylrhodamine-conjugated goat anti-mouse IgG antibody (1:250; T2762; Thermo Fisher Scientific); 
Rhodamine (TRITC)-conjugated affiniPure goat anti-rabbit IgG (H + L) antibody (1:500; Code: 111-025-003; 
Jackson ImmunoResearch Laboratories, PA 19390, USA); biotinylated goat anti-mouse IgG antibody (1:250; 
BA-9200; Vector Laboratories, CA 94010, USA) and anti-rabbit IgG (1:250; BA-1000; Vector Laboratories).
For immunofluorescence labeling3, eyeball sections were washed (PBS, 15 min → 0.1% Triton X-100 in PBS, 
15 min → PBS, 15 min), incubated with blocking solution [2% normal goat serum (S-1000; Vector Laboratories), 
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5% bovine serum albumin (A3294-50G; Sigma-Aldrich) and 0.1% Triton X-100 in PBS] for 2 h, and then incu-
bated with primary antibody diluted in blocking solution overnight at 4 °C. The sections were washed and then 
incubated with secondary antibody diluted in blocking solution for 4 h. To minimize autofluorescence, eyeball 
sections were sometimes treated with 0.3% H2O2 in 50% methanol diluted in PBS for 20 min before they were 
incubated with blocking solution (Fig. 3). For immunoperoxidase labeling3, eyeball sections were washed, treated 
with 0.3% H2O2 in methanol for 20 min, washed, incubated in blocking solution mixed with Avidin D (1:50; 
Avidin/Biotin Blocking kit; SP-2001; Vector Laboratories) for 2 h, washed twice in PBS, and then incubated in pri-
mary antibody diluted with blocking solution mixed with Biotin (1:50; Avidin/Biotin Blocking kit) overnight at 
4 °C. The sections were washed, incubated with biotinylated secondary antibody diluted in blocking solution for 
4 h, washed, incubated in a mixture of Avidin and Biotin Complex (1:50 each; Vectastain ABC Elite kit; PK-6100; 
Vector Laboratories) for 2 h, washed, and then treated with DAB solution (DAB substrate kit; SK-4100; Vector 
Laboratories). After labeling, tissues were washed and sometimes bleached3 (Fig. 2b,c and Supplementary Fig. 2b). 
They were counterstained to visualize nuclei with either DAPI (4,6-diamidino-2-phenylindole; 1:25,000; D1306; 
Thermo Fisher Scientific) or TO-PRO-3 Iodide (1:10,000; T3605; Thermo Fisher Scientific), and finally mounted 
with 90% glycerol in PBS or Vectashield mounting medium (H-1000; Vector Laboratories).
Image analysis. Transgenic newts were monitored under a fluorescence dissecting microscope (M165 FC) 
which was installed with filter sets specific to AmCyan (CFP; Exciter: 436/20 nm; Emitter: 480/40 nm; Leica 
Microsystems), YFP (YFP; Exciter: 500/20 nm; Emitter: 535/30 nm; Leica Microsystems) and mCherry (Exciter: 
XF1044, 575DF25; Emitter: XF3402, 645OM75; Opto Science, Tokyo, Japan). Images were taken by a digital cam-
era system (EOS Kiss x7i; Canon, Tokyo, Japan) attached to the microscope. Eyeball sections were examined on a 
fluorescence microscope (BX50; Olympus, Tokyo, Japan) which was also installed with the same filter sets as well 
as standard filter sets for EGFP, Texas red and DAPI. Their images were taken by a charge-coupled device camera 
system (DP73; cellSens Standard 1.6; Olympus) attached to this microscope (BX50; Olympus) or by a confocal 
microscope system (LSM510; LSM 5.0 Image Browser software; Carl Zeiss, Germany). Images were analyzed 
with software for the image acquisition systems and in Photoshop CS5 Extended (Adobe Systems, San Jose, CA). 
Figures and panels were prepared using Photoshop CS5 Extended. Images, brightness, contrast and sharpness 
were adjusted according to the journal’s guidelines.
Cell counting and statistics. To count the number of PCNA+ RPE-derived cells (Fig. 2d–f), eyeball sec-
tions were double-labelled with antibodies against PCNA and RPE65, and stained with To-pro-3 to visualize cell 
nuclei (see above). Sections were carefully examined for their immunoreactivities by confocal microscopy (see 
above). PCNA-immunoreactive nuclei were counted in all nuclei (To-pro-3 stained) of RPE-derived cells on 10 
days [Stage E-1; these cells were still RPE65+ in both Pax6 KD and control conditions (Fig. 2e)], and in all nuclei 
of RPE-derived cell aggregates in between the leading ends of CMZ-NR on 26 days po [these cells were either 
RPE65− or RPE65+ (Fig. 2f)]. Of note, in PCNA immunohistochemistry under the current conditions using 
juvenile eyes, non-specific binding of primary antibody sometimes occurred in the intercellular space within 
regrowing NR from CMZ (CMZ-NR) and in the extracellular matrix surrounding RPE cells migrating from the 
ends of regrowing RPE. For statistics, a section containing aggregates of RPE-derived cells was selected per eye-
ball at random from those around the centre of the eyeball, and the cell count data from the section was used as 
representative data. Data were collected from at least three eyeballs in both the control and test conditions, and 
presented as the mean ± SE. Statistical differences between the control and test was evaluated by a Student’s t-test.
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